中智全球(06819.HK)合資公司與太醫之原簽合作協議
中智全球(06819.HK)公布,旗下合資公司北京仁正醫德與大醫之原簽署合作協議。雙方將以仁正醫德自有的醫療機構合規管理服務雲平台和慢病管理服務雲平台,以及大醫之原近兩萬人的註冊患者為基礎,為患者提供數字化的居家監測解決方案,並在此基礎上開發基於數字化的罕見病患者遠程健康管理方案。
此外,中智全球透過仁正醫德平台的國內與海外醫療資源,可以為大醫之原的杜氏肌營養不良症、肌肉萎縮症等罕見病患者提供線上問診,藥品諮詢,過程會診,緊急狀況處理等醫療服務。雙方將繼續探索加深合作,針對選定的罕見疾病,開展罕見病治療、康復、併發症治療方面的研究項目。
通過此次合作,大醫之原的罕見病患者可以透過仁正醫德提供的「會員應急醫療服務」,得到仁正醫德的醫療診療服務。雙方計劃於未來一年內達成仁正醫德愛惜你平台2,000名付費會員的目標,三年內雙方預計將通過引入全球醫療資源、圍繞罕見病患者開發全週期服務等措施,累計20,000名付費會員。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.